Korea Nutritional Health and Nutritional Examination Survey. Korea Health Statistics 2014: Korea National Health and Nutrition Examination Survey (KNHANES VI-2) [Internet]. Cheongju: Center for Disease and Prevention; 2012 [cited 2015 Dec 23].
Mine Y, Wong AHK, Jiang B. Fibrinolytic enzymes in Asian traditional fermented foods. Food Res Int 2005; 38: 243-50.
Seo JH, Lee SP. Production of fibrinolytic enzyme from soybean grits fermented by Bacillus firmus NA-1. J Med Food 2004; 7: 442-9.
Fujita M, Nomura K, Hong K, Ito Y, Asada A, Nishimuro S. Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochem Biophys Res Commun 1993; 197: 1340-7.
Sumi H, Hamada H, Tsushima H, Mihara H, Muraki H. A novel fibrinolytic enzyme (nattokinase) in the vegetable cheese natto; a typical and popular soybean food in the Japanese diet. Experientia 1987; 43: 1110-1.
Omura K, Hitosugi M, Kaketani K, Zhu X, Maeda H, Tokudome S. Fibrinolytic and anti-thrombotic effect of NKCP, the protein layer from Bacillus subtilis (natto). Biofactors 2004; 22: 185-7.
Sumi H, Sasaki K, Toki N, Robbins KC. Oral administration of urokinase. Thromb Res 1980; 20: 711-4.
Miller M, Makise K. Natto and its active ingredient nattokinase: a potent and safe thrombolytic agent. Alternative Compl Ther 2002; 8: 157-64.
Omura K, Hitosugi M, Zhu X, Ikeda M, Maeda H, Tokudome S. A newly derived protein from Bacillus subtilis natto with both antithrombotic and fibrinolytic effects. J Pharmacol Sci 2005; 99: 247-51.
Yamashita T, Oda E, Giddings JC, Yamamoto J. The effect of dietary bacillus natto productive protein on in vivo endogenous thrombolysis. Pathophysiol Haemost Thromb 2003; 33: 138-43.
Borawski J, Myśliwiec M. Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients. Clin Appl Thromb Hemost 2001; 7: 296-9.
Wada Y, Kurihara M, Toyofuku M, Kawamura M, Iida H, Kayamori Y, et al. Analytical goals for coagulation tests based on biological variation. Clin Chem Lab Med 2004; 42: 79-83.
Machin D, Campbell MJ. Design of studies for medical research. Hoboken (NJ): Wiley; 2005.
Homma K, Wakana N, Suzuki Y, Nukui M, Daimatsu T, Tanaka E, et al. Treatment of natto, a fermented soybean preparation, to prevent excessive plasma vitamin K concentrations in patients taking warfarin. J Nutr Sci Vitaminol (Tokyo) 2006; 52: 297-301.
Sumi H, Hamada H, Nakanishi K, Hiratani H. Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematol 1990; 84: 139-43.